デフォルト表紙
市場調査レポート
商品コード
989842

オステオバイオロジクスの世界市場:製品別、エンドユーザー別、アプリケーション別の予測(2026年まで)- COVID-19の累積的影響

Osteobiologics Market Research Report by Product, by End-User, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.75円
オステオバイオロジクスの世界市場:製品別、エンドユーザー別、アプリケーション別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のオステオバイオロジクスの市場規模は、2020年の179億4,998万米ドルから、2025年末までに201億6,235万米ドルに拡大すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた比類のない世界の公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されています。

当レポートは、世界のオステオバイオロジクス市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、製品・エンドユーザー・アプリケーション・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査目的
  • 市場セグメンテーションとカバレッジ
  • 調査期間
  • 通貨と価格
  • 言語
  • 制約事項
  • 利害関係者

第2章 調査方法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査計画
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場展望
  • エンドユーザー別市場の展望
  • 製品別市場の展望
  • アプリケーション別市場の展望
  • 地域別市場の展望
  • 競合他社の展望

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 製品別市場

  • イントロダクション
  • 同種移植
  • 骨髄穿刺液濃縮物
  • 骨形成タンパク質
  • 脱灰骨マトリックス
  • 多血小板血漿
  • 合成整形外科
  • ビスコサプリメント製品

第7章 エンドユーザー別市場

  • イントロダクション
  • 歯科医院・設備
  • 病院
  • 研究・学術機関
  • 専門クリニック

第8章 アプリケーション別市場

  • イントロダクション
  • 骨折の回復
  • 顎顔面および歯科用アプリケーション
  • 変形性関節症および変性関節炎
  • 軟部組織の損傷
  • 脊椎固定術

第9章 南北アメリカ市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカ市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第13章 企業プロファイル

  • DePuy Synthes
  • Fuse Medical, Inc.
  • K2M, Inc.
  • LifeNet Health, Inc.
  • Medtronic
  • NuVasive, Inc.
  • Orthofix
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Zimmer Biomet

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 6. GLOBAL OSTEOBIOLOGICS MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL OSTEOBIOLOGICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MARROW ASPIRATE CONCENTRATE, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MARROW ASPIRATE CONCENTRATE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEIN, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEIN, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRICES, 2018-2026 (USD BILLION)
  • FIGURE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRICES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PLASMA-RICH PROTEIN, 2018-2026 (USD BILLION)
  • FIGURE 20. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PLASMA-RICH PROTEIN, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 21. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC ORTHOBIOLOGICS, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC ORTHOBIOLOGICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY VISCO-SUPPLEMENTATION PRODUCTS, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY VISCO-SUPPLEMENTATION PRODUCTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 26. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2026
  • FIGURE 28. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DENTAL CLINICS AND FACILITIES, 2018-2026 (USD BILLION)
  • FIGURE 29. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DENTAL CLINICS AND FACILITIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 30. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
  • FIGURE 31. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2026 (USD BILLION)
  • FIGURE 33. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 34. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2026 (USD BILLION)
  • FIGURE 35. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPECIALTY CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 36. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 37. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 39. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FRACTURE RECOVERY, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FRACTURE RECOVERY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MAXILLOFACIAL AND DENTAL APPLICATIONS, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MAXILLOFACIAL AND DENTAL APPLICATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SOFT-TISSUE INJURIES, 2018-2026 (USD BILLION)
  • FIGURE 46. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SOFT-TISSUE INJURIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2026 (USD BILLION)
  • FIGURE 48. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 49. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 50. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 52. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. CANADA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. CALIFORNIA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. FLORIDA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. ILLINOIS OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. NEW YORK OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. OHIO OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. PENNSYLVANIA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. TEXAS OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 65. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 66. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 67. CHINA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. INDIA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 76. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 77. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 78. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 79. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 80. ITALY OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 81. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 82. QATAR OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 83. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 84. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 85. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 86. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 87. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 88. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 89. GLOBAL OSTEOBIOLOGICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 90. GLOBAL OSTEOBIOLOGICS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 91. GLOBAL OSTEOBIOLOGICS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 92. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL OSTEOBIOLOGICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL OSTEOBIOLOGICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MARROW ASPIRATE CONCENTRATE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRICES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PLASMA-RICH PROTEIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC ORTHOBIOLOGICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY VISCO-SUPPLEMENTATION PRODUCTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DENTAL CLINICS AND FACILITIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPECIALTY CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FRACTURE RECOVERY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MAXILLOFACIAL AND DENTAL APPLICATIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SOFT-TISSUE INJURIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. AMERICAS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. ARGENTINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. BRAZIL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. CANADA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. CANADA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. CANADA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. MEXICO OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. UNITED STATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. CALIFORNIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. CALIFORNIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. CALIFORNIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. FLORIDA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. FLORIDA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. FLORIDA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. ILLINOIS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. ILLINOIS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. ILLINOIS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. NEW YORK OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. NEW YORK OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. NEW YORK OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. OHIO OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. OHIO OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. OHIO OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. PENNSYLVANIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. PENNSYLVANIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. PENNSYLVANIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. TEXAS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. TEXAS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. TEXAS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. CHINA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. CHINA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. CHINA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. INDIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. INDIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. INDIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. INDONESIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. JAPAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. MALAYSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. PHILIPPINES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. SOUTH KOREA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. THAILAND OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. FRANCE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. GERMANY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. ITALY OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. ITALY OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. ITALY OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. NETHERLANDS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. QATAR OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. QATAR OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. QATAR OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. RUSSIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 113. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 114. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 115. SAUDI ARABIA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 116. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 117. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 118. SOUTH AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 119. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 120. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 121. SPAIN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 122. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 123. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 124. UNITED ARAB EMIRATES OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 125. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 126. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 127. UNITED KINGDOM OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 128. GLOBAL OSTEOBIOLOGICS MARKET: SCORES
  • TABLE 129. GLOBAL OSTEOBIOLOGICS MARKET: BUSINESS STRATEGY
  • TABLE 130. GLOBAL OSTEOBIOLOGICS MARKET: PRODUCT SATISFACTION
  • TABLE 131. GLOBAL OSTEOBIOLOGICS MARKET: RANKING
  • TABLE 132. GLOBAL OSTEOBIOLOGICS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 133. GLOBAL OSTEOBIOLOGICS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 134. GLOBAL OSTEOBIOLOGICS MARKET: MERGER & ACQUISITION
  • TABLE 135. GLOBAL OSTEOBIOLOGICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 136. GLOBAL OSTEOBIOLOGICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 137. GLOBAL OSTEOBIOLOGICS MARKET: INVESTMENT & FUNDING
  • TABLE 138. GLOBAL OSTEOBIOLOGICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 139. GLOBAL OSTEOBIOLOGICS MARKET: LICENSE & PRICING
  • TABLE 140. GLOBAL OSTEOBIOLOGICS MARKET: CONTACT DETAILS
目次
Product Code: MRR-036C5CF3B4C1

The Global Osteobiologics Market size was estimated at USD 17.94 Billion in 2020 and expected to reach USD 18.46 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 3.19% to reach USD 21.67 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Osteobiologics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Osteobiologics Market was studied across Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-rich Protein, Synthetic Orthobiologics, and Visco-supplementation Products.

Based on End-User, the Osteobiologics Market was studied across Dental Clinics and Facilities, Hospitals, Research & Academic Institutes, and Specialty Clinics.

Based on Application, the Osteobiologics Market was studied across Fracture Recovery, Maxillofacial and Dental Applications, Osteoarthritis and Degenerative Arthritis, Soft-tissue Injuries, and Spinal Fusion.

Based on Geography, the Osteobiologics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Osteobiologics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Osteobiologics Market, including DePuy Synthes, Fuse Medical, Inc., K2M, Inc., LifeNet Health, Inc., Medtronic, NuVasive, Inc., Orthofix, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Osteobiologics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Osteobiologics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Osteobiologics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Osteobiologics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Osteobiologics Market?
  • 6. What is the market share of the leading vendors in the Global Osteobiologics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Osteobiologics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. End-User Outlook
  • 3.4. Product Outlook
  • 3.5. Application Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of bone infections, osteoporosis, and osteonecrosis
      • 5.1.1.2. Growth in aging population and age related bone weakening concerns
      • 5.1.1.3. Acceptance over benefits offered by Osteobiologic substances
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of bisphosphonates
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising number of spine fusion surgeries
      • 5.1.3.2. Research & Development in the arena of osteobiologics
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and dearth of skilled professionals
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Osteobiologics Market, by Product

  • 6.1. Introduction
  • 6.2. Allografts
  • 6.3. Bone Marrow Aspirate Concentrate
  • 6.4. Bone Morphogenic Protein
  • 6.5. Demineralized Bone Matrices
  • 6.6. Plasma-rich Protein
  • 6.7. Synthetic Orthobiologics
  • 6.8. Visco-supplementation Products

7. Osteobiologics Market, by End-User

  • 7.1. Introduction
  • 7.2. Dental Clinics and Facilities
  • 7.3. Hospitals
  • 7.4. Research & Academic Institutes
  • 7.5. Specialty Clinics

8. Osteobiologics Market, by Application

  • 8.1. Introduction
  • 8.2. Fracture Recovery
  • 8.3. Maxillofacial and Dental Applications
  • 8.4. Osteoarthritis and Degenerative Arthritis
  • 8.5. Soft-tissue Injuries
  • 8.6. Spinal Fusion

9. Americas Osteobiologics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Osteobiologics Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Osteobiologics Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. DePuy Synthes
  • 13.2. Fuse Medical, Inc.
  • 13.3. K2M, Inc.
  • 13.4. LifeNet Health, Inc.
  • 13.5. Medtronic
  • 13.6. NuVasive, Inc.
  • 13.7. Orthofix
  • 13.8. Stryker Corporation
  • 13.9. Wright Medical Group N.V.
  • 13.10. Zimmer Biomet

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details